Pediatric Right Ventricular Cardiac Steatosis following Immunosuppressive Treatment

Diana Kozman1, Carlos R Abramowsky2, Janet Poulik1

  • 1Pathology, Children's Hospital of Michigan, Detroit, Michigan, USA.

Insights

Immunosuppression in children may cause fatty infiltration in the right ventricle, impacting heart health. This study investigated immunosuppressed pediatric patients and found a link to this condition.

Area of Science:

  • Pediatric Pathology
  • Cardiovascular Research
  • Immunology

Background:

  • Right ventricular fatty infiltration is linked to reduced graft survival in pediatric cardiac allografts.
  • Immunosuppressive drugs are a potential cause, prompting investigation into shared factors.
  • This study examined immunosuppressed children and pediatric autopsy hearts.

Purpose of the Study:

  • To investigate the association between immunosuppression and right ventricular fatty infiltration in pediatric patients.
  • To explore potential links between immunosuppressive therapy and cardiac pathology in children.

Main Methods:

  • Analysis of 61 pediatric autopsies from immunosuppressed children (corticosteroids for tumors, transplants, or chronic conditions).
  • Comparison with 62 control pediatric autopsies (died from non-medical causes).
  • Histopathological examination of cardiac H&E slides for right ventricular fatty infiltration.

Main Results:

  • Significantly increased right ventricular fatty infiltration observed in non-cardiac transplanted, immunosuppressed patients compared to controls.
  • No index patients exhibited features of arrhythmogenic right ventricular dysplasia.

Conclusions:

  • Immunosuppression is a potential contributing factor to right ventricular fatty infiltration in childhood.
  • This finding has implications for understanding long-term cardiac health in pediatric patients undergoing immunosuppressive therapy.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
246
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
375
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
309